EI research strategy

Research Strategy

We know that prompt diagnosis and treatment in all types of encephalitis is critically important, both in saving lives and limiting brain injury, as is rehabilitation for those suffering sequelae which is an area with limited evidence. We are also aware that facilities for diagnosis, treatment and rehabilitation vary greatly depending on location.

Diagnosis

Increasingly we recognise the additional challenges of emerging infections, with specific geographical variation. Therefore, we are keen to support research which makes diagnosis quicker and more specific, particularly with relevance to these emerging and future challenges, and to disseminate new knowledge effectively. We are also be interested in research that explores correlations between delays in diagnosis, treatment and outcome/levels of disability.

Treatment

Treatments are often limited in infectious aetiologies of encephalitis and we know from experience with COVID-19 that sometimes widely available treatments (for example dexamethasone), can be very effective in reducing symptoms, although we know little about the longer term benefits. We are interested in supporting research that explores the use of repurposing existing medications or the identification of targets for novel immunomodulatory agents in both infectious and autoimmune causes of encephalitis, along with their effects, not only during the acute stages but thereafter during rehabilitation.

These aims will require the establishment of fuller registries and clinical trial platforms/networks in encephalitis to support specific studies and trials in the future.

Recovery and rehabilitation

There is currently very little good quality research on outcomes from encephalitis.

Research into the recovery and rehabilitation of patients who have had encephalitis has been limited. We know little about patient recovery pathways, which forms of rehabilitation are more effective, what rehabilitation services are being offered to patients following encephalitis, what are the most effective
interventions in maximising people’s clinical outcomes and quality of life and when should rehabilitation begin.

In addition to cognitive and physical outcomes, research that explores behavioural, mental health and social outcomes are much needed. This should include-patient derived input to inform outcome metrics.

Use of animals in medical research

Encephalitis International supports the position of the Association of Medical Research Charities (AMRC) on the issue of using animals in research.

Encephalitis International will only consider funding applications for research that tests on animals on a case-by-case basis, where there is evidence of no other model or known alternative, and only for studies being conducted in the UK.

Encephalitis International uses expert peer-review to ensure that we fund only high-quality research where the benefits to people and animal health outweigh any harms to animals.

Encephalitis International funds research which complies with UK regulation and support the principle of the AMRC of 3Rs to replace, reduce and refine the use of animals in research.

Encephalitis International wishes to actively support research which is working toward eradicating the need for animal testing and will always choose to fund studies that do not test on animals over and above equivalent studies that do.

View AMRC statement

View Encephalitis International’s ‘Animal Research Guidance’ document

Encephalitis International Research Subcommittee

Encephalitis International has an expert Scientific Advisory Panel who provides Encephalitis International
with expert professional resources, advice and also assist with clinical matters. Members of the Panel
include highly regarded experts from neurological, neuropsychological, neuropsychiatric, neuroimmunological,
paediatric, therapeutic and other relevant fields from the UK and abroad. The Panel has
formed two subcommittees: Research and Conference.

The Research Subcommittee, along with the lay grant reviewers, provide advice to Encephalitis International
as to whether individual research grant applications merit charity funding. The Research Subcommittee members have a duty to bring an independent judgement to bear on grant applications at every stage of submission and on all issues considered at virtual and face‐to‐face panel meetings.

Encephalitis International Research Subcommittee

Prof Angela Vincent (Chair)

Prof Benedict Michael

Dr Thomas Pollak

Prof Michael Wilson

Dr Sophie Binks

Assoc Prof Kiran Thakur

Dr Tina Damodar

Apply for a grant

Encephalitis International is very active in the field of research by taking part in research, collaborating with researchers and making grants and awards.

Grants available
High five
Main Menu